Agenda – 10th Aggregate Spend and Open Payments Conference

  • DAY ONE
  • DAY TWO

DAY ONE

 TUESDAY, JUNE 18

8:45 – 9:00

Chairperson’s Opening Remarks
Heather McCollum, J.D., MHA, CCEP-I, Director, Compliance, SHIONOGI

9:00 – 9:45

Analyze the Differences in State and Federal Reporting Regulations
Bill Friedrich, Senior Manager, Compliance, HIKMA PHARMACEUTICALS

9:45 – 10:30

Explore Compliance Dashboards and Develop Meaningful Data Visuals
Ishita Arora, Compliance Consultant, HORIZON PHARMA PLC
Melissa Kaschak, CPA, CFE, CISA, Compliance Operations, OLYMPUS

10:30 – 11:00

Networking Break

11:00 – 11:45

CMS Address: Updates to the Sunshine Act and Open Payments System
Robin Usi, Director, Division of Data and Informatics, Center for Program Integrity, CENTERS FOR MEDICARE & MEDICAID SERVICES

11:45 – 12:30

Make Strategic Business Decisions by Leveraging Technology and Transparency Data
Bryan Stinehour, Senior Product Manager, MEDISPEND

12:30 – 1:30

Luncheon

1:30 – 2:15

Optimize Aggregate Spend Data Collection, Validation and Reporting
Sharon Muscato, Director, Transparency and Compliance Operations, ALEXION PHARMACEUTICALS

2:15 – 3:15

CASE STUDY: Manage Disputes Effectively and Organize Feedback to Improve Future Reporting Processes
Heather McCollum, J.D., MHA, CCEP-I, Director, Compliance, SHIONOGI

3:15 – 3:45

Networking Break

3:45 – 4:30

Understand the Landscape of State Transparency and Spend Restrictions
Sheea Sybblis, Senior Counsel, BOEHRINGER INGELHEIM

4:30 – 5:15

PANEL: Discuss High-Risk Areas and Emerging Trends in Transparency and Compliance
Moderated by:
Heather McCollum, J.D., MHA, CCEP-I, Director, Compliance, SHIONOGI

Charlene E. Davis, Associate Vice President and Head of Healthcare Compliance North America, SUN PHARMACEUTICAL INDUSTRIES
Sheea Sybblis, Senior Counsel, BOEHRINGER INGELHEIM
Donna White, Vice President, Contracts and Compliance, CHIESI USA
Danny Smout, Senior Solution Consultant, SAP CONCUR

5:15 – 5:30

Chairperson’s Closing Remarks
Heather McCollum, J.D., MHA, CCEP-I, Director, Compliance, SHIONOGI

5:30 – 5:30

Day One Concludes


DAY TWO

 WEDNESDAY, JUNE 19

8:45 – 9:00

Chairperson’s Recap of Day One
Heather McCollum, J.D., MHA, CCEP-I, Director, Compliance, SHIONOGI

9:00 – 9:45

Utilize Aggregate Spend Data As Part of an Effective Auditing and Monitoring Program
Amy Valiante Ross, Compliance and Data Protection Officer, DRAGER

9:45 – 10:30

Define the Terms of Appropriate and Ethical Interactions Between Manufacturers and HCPs
Kari Loeser, U.S. Healthcare Compliance Officer, RELYPSA

10:30 – 11:00

Networking Break

11:00 – 11:45

Explore Global Compliance Initiatives Through Foreign Regulations, the Sunshine Act, and GDPR
Bryan Stefanski, Compliance Director, SIEMENS HEALTHINEERS
Natalia Morozkina, Compliance Manager, OTSUKA PHARMACEUTICAL COMPANIES

11:45 – 12:30

Utilize Open Payments Data to Quantify and Track the Value of HCP Partnerships
Nicodemo Fiorentino, Esq., Senior Manager, Compliance Operations and Transparency, SUN PHARMA
Thomas Sullivan, Editor/Publisher, POLICY AND MEDICINE

12:30 – 1:30

Luncheon

1:30 – 2:15

Identify Compliance Obstacles and Streamline Processes Associated With Field Sales Activities to Mitigate Risk
Sergio Alegre, Vice President, Global Compliance, OSMOTICA PHARMACEUTICAL

2:15 – 3:15

DOJ ENFORCEMENT PANEL: Current Trends and Relevant Ethical Considerations
Bernard Cooney, Assistant United States Attorney, District of New Jersey, U.S. DEPARTMENT OF JUSTICE
Daniel Font, CIIP-US, CIPM, Director, Compliance Investigations, Policy and Training, DAIICHI SANKYO
Joseph Mack, Senior Compliance Counsel, BAYER

3:15 – 3:30

Chairperson’s Closing Remarks
Heather McCollum, J.D., MHA, CCEP-I, Director, Compliance, SHIONOGI